In vitro imaging techniques in Neurodegenerative diseases

被引:16
作者
Langstrom, Bengt [1 ]
Andren, Per E.
Lindhe, Orjan
Svedberg, Marie
Hall, Hakan
机构
[1] Uppsala Univ, Dept Biochem & Organ Chem, Uppsala, Sweden
[2] Uppsala Imanet GE Hlth Care, Uppsala, Sweden
[3] Uppsala Univ, Lab Biol & Med Mass Spectrometry, Uppsala, Sweden
[4] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden
关键词
Alzheimer's disease; autoradiography; MALDI mass spectrometry; neurodegenerative; diseases; Parkinson's disease; PET;
D O I
10.1007/s11307-007-0088-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Neurodegeneration induces various changes in the brain, changes that may be investigated using neuroimaging techniques. The in vivo techniques are useful for the visualization of major changes, and the progressing abnormalities may also be followed longitudinally. However, to study and quantify minor abnormalities, neuroimaging of postmortem brain tissue is used. These in vitro methods are complementary to the in vivo techniques and contribute to the knowledge of pathophysiology and etiology of the neurodegenerative diseases. In vitro radioligand autoradiography has given great insight in the involvement of different neuronal receptor systems in these diseases. Data on the dopamine and cholinergic systems in neurodegeneration are discussed in this review. Also, the amyloid plaques are studied using in vitro radioligand autoradiography. Using one of the newer methods, imaging matrix-assisted laser desorption ionization mass spectrometry, the distribution of a large number of peptides and proteins may be detected in vitro on brain cryosections. In this overview, we describe in vitro imaging techniques in the neurodegenerative diseases as a complement to in vivo positron emission tomography and single photon emission computed tomography imaging.
引用
收藏
页码:161 / 175
页数:15
相关论文
共 114 条
[1]   Automated acoustic matrix deposition for MALDI sample preparation [J].
Aerni, HR ;
Cornett, DS ;
Caprioli, RM .
ANALYTICAL CHEMISTRY, 2006, 78 (03) :827-834
[2]  
ALZHEIMER A, 1907, PECULIAR DIS CEREBRA, V1, P3
[3]   What causes the build-up of ubiquitin-containing inclusions in Parkinson's disease? [J].
Andersen, JK .
MECHANISMS OF AGEING AND DEVELOPMENT, 2000, 118 (1-2) :15-22
[4]   Amyloid load and cerebral atrophy in Alzheimer's disease:: An 11C-PIB positron emission tomography study [J].
Archer, Hilary A. ;
Edison, Paul ;
Brooks, David J. ;
Barnes, Jo ;
Frost, Chris ;
Yeatman, Toni ;
Fox, Nick C. ;
Rossor, Martin N. .
ANNALS OF NEUROLOGY, 2006, 60 (01) :145-147
[5]  
Bach PH, 1996, ATLA-ALTERN LAB ANIM, V24, P893
[6]   The dopamine transporter: role in neurotoxicity and human disease [J].
Bannon, MJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2005, 204 (03) :355-360
[7]  
Bergstrom Mats, 2003, Mol Imaging Biol, V5, P390, DOI 10.1016/j.mibio.2003.09.004
[8]  
Braak H, 1998, PROG BRAIN RES, V117, P267
[9]   STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].
BRAAK, H ;
BRAAK, E .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :271-278
[10]  
Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO